[1]
F. L. . Barroso and . M. A. Estrin, “Causal relationship between GLP-1 agonists and depressive symptomatology in patients with type 2 Diabetes: A systematic review”, Salud, Ciencia y Tecnología - Serie de Conferencias, vol. 3, p. 942, Jun. 2024, doi: 10.56294/sctconf2024942.